Drug Repurposing Against Covid-19 Through Anticytokine Activity

Abstract

Drug repurposing or repositioning is a well-known strategy that seeks to deploy existing licensed drugs for newer indications and provides the quickest possible transition from bench to clinics for unmet therapeutic needs. Given the current, urgent, and dire need for effective therapies against novel coronavirus-19, this approach is particularly appealing. The present review will focus on the repurposing efficacy of the currently used drugs against COVID-19 that act through anticytokine activity.